GERN - Geron Corporation
1.9201 0.00 (0.01%)
After hours: 5:59PM EDT
| Previous Close | 1.9200 |
| Open | 1.9300 |
| Bid | 1.9000 x 4000 |
| Ask | 1.9400 x 38800 |
| Day's Range | 1.8600 - 1.9578 |
| 52 Week Range | 0.9500 - 6.9900 |
| Volume | 2,325,097 |
| Avg. Volume | 3,594,753 |
| Market Cap | 357.9M |
| Beta (3Y Monthly) | 2.53 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1530 |
| Earnings Date | May 4, 2017 - May 8, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.42 |
- Motley Fool•4 days ago
3 Cancer Treatment Stocks to Buy in April
These three cancer stocks have tremendous upside potential.
- GlobeNewswire•6 days ago
Geron Expands Senior Leadership of Its Development Team
MENLO PARK, Calif., April 18, 2019 -- Geron Corporation (Nasdaq: GERN) today announced an expansion of its development team’s senior leadership with the addition of three.
- Benzinga•14 days ago
Geron's Blood Cancer Candidate Creates Buying Opportunity, Needham Says In Upgrade
Geron Corporation (NASDAQ: GERN ) announced in September that Johnson & Johnson (NYSE: JNJ )'s Janssen unit opted to terminate a collaboration and licensing agreement between the companies for imetelstat, ...
- Reuters•16 days ago
BRIEF-China's Geron Says Controlling Shareholder Plans To Unload Up To 6 Pct Stake In The Company
April 8 (Reuters) - Geron Co Ltd: * SAYS CONTROLLING SHAREHOLDER PLANS TO UNLOAD UP TO 6 PERCENT STAKE IN THE COMPANY WITHIN SIX MONTHS Source text in Chinese: https://bit.ly/2IiMtRX Further company coverage: ...
- Zacks•18 days ago
Why Is Geron (GERN) Up 27.3% Since Last Earnings Report?
Geron (GERN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GlobeNewswire•21 days ago
Geron to Present at Needham Healthcare Conference
MENLO PARK, Calif., April 02, 2019 -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to.
- GlobeNewswire•27 days ago
Geron Appoints Two New Independent Board Members
MENLO PARK, Calif., March 28, 2019 -- Geron Corporation (Nasdaq: GERN) today announced the appointments of Dawn C. Bir and Elizabeth G. O’Farrell as independent members of its.
- Thomson Reuters StreetEvents•29 days ago
Edited Transcript of GERN earnings conference call or presentation 7-Mar-19 9:30pm GMT
Q4 2018 Geron Corp Earnings Call
- GlobeNewswire•last month
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 78,400 shares of Geron common stock as inducements to two newly-hired employees in connection with commencement of employment with the Company. The stock options were granted on March 20, 2019 at an exercise price of $1.77 per share, which is equal to the closing price of Geron common stock on the date of grant. Each stock option granted has a 10-year term and vests over four years, with 12.5% of the shares underlying the option vesting on the six-month anniversary of commencement of employment and the remaining shares vesting over the following 42 months in equal installments of whole shares, subject to continued employment with Geron through the applicable vesting dates.
- Motley Fool•last month
3 Penny Stocks That Could Make You Rich -- or Regretful
These three penny stocks have enormous upside potential, but they each come with a hefty dose of risk.
- Zacks•last month
Do Options Traders Know Something About Geron (GERN) Stock We Don't?
Investors need to pay close attention to Geron (GERN) stock based on the movements in the options market lately.
- Motley Fool•last month
3 Small-Cap Stocks With Big-Cap Potential
Warning: Small-cap stocks are risky, but the risk might be worth taking sometimes. Like with these three companies.
- Zacks•2 months ago
Geron's (GERN) Q4 Loss In Line, Revenues Beat, Stock Up
Geron (GERN) posts loss in line with the estimate in fourth-quarter 2018 but beats on revenues. Operating expenses increase on a year-over-year basis.
Motley Fool•2 months agoGeron Corportaion (GERN) Q4 2018Earnings Conference Call Transcript
GERN earnings call for the period ending December 31, 2018.
- GlobeNewswire•2 months ago
Geron Corporation Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Events
MENLO PARK, Calif., March 07, 2019 -- Geron Corporation (Nasdaq: GERN) today reported financial results for the fourth quarter and full year ended December 31, 2018 and recent.
- Motley Fool•2 months ago
Why Geron Skyrocketed 27% in February
Investors are hopeful that this struggling biotech is about to get back on track.
- Motley Fool•2 months ago
The 3 Oldest Members of Biotech's Billion-Burned Club
These biopharmaceutical startups have been losing their investors' money for decades.
- GlobeNewswire•2 months ago
Geron to Announce Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019
Geron Corporation (GERN) today announced that it will release its fourth quarter and full year 2018 financial results after the market closes on Thursday, March 7, 2019 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results as well as recent events at 4:30 p.m. ET the same day. Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
- Motley Fool•2 months ago
Could Geron Be a Millionaire-Maker Stock?
Can this penny biotech stock make early-bird investors rich?
- Motley Fool•2 months ago
Why Geron Stock Briefly Spiked Today
This morning's move followed an upgrade by BTIG.
- GlobeNewswire•2 months ago
Analysis: Positioning to Benefit within National Oilwell Varco, Centene, Paylocity Holding, NorthStar Realty Europe, Geron, and NACCO Industries — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Feb. 08, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Zacks•3 months ago
Are Options Traders Betting on a Big Move in Geron (GERN) Stock?
Investors need to pay close attention to Geron (GERN) stock based on the movements in the options market lately.
- ACCESSWIRE•3 months ago
Biotech Stocks to Watch
HENDERSON, NV / ACCESSWIRE / February 5, 2019 / Some consider the small-cap and mid-cap - ''smid-cap'' - zone with market caps of $5 billion or less, a bit risky. They aren't wrong. However, if you can ...
- Simply Wall St.•3 months ago
How Much is Geron Corporation’s (NASDAQ:GERN) CEO Getting Paid?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! In 2011 Chip Scarlett was appointed CEO Read More...
- GlobeNewswire•3 months ago
Geron Announces Expansion of Leadership Team with Appointment of Chief Medical Officer
Geron Corporation (GERN) today announced an expansion of its leadership team with the appointment of a new chief medical officer to support the Company’s clinical drug development efforts in hematology-oncology. “As we transition to a late-stage development company, we are very pleased to welcome Dr. Aleksandra Rizo to Geron as Chief Medical Officer,” said John A. Scarlett, M.D., Chairman and Chief Executive Officer.
